v3.26.1
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ / shares in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Expenses:    
Consulting (Note 13) $ 60,000 $ 93,250
Research and development (Note 10) 1,008 6,926
Selling, general and administrative (Notes 9 and 13) 258,227 223,545
Share-based compensation (Notes 7 and 13) 0 5,969
Loss from operations (319,235) (329,690)
Interest income 96 2,330
Net loss (319,139) (327,360)
Other comprehensive loss    
Currency translation differences (9,175) 1,686
Total comprehensive loss $ (328,314) $ (325,674)
Net loss per share – basic and diluted (in dollars per share) $ (0) $ (0)
Weighted average number of common shares outstanding – basic and diluted (in shares) 91,422,569 91,422,569